Sir,
The report on CNS Pseudallescheria boydii infection from Turkey by Alpaydın et al. [1] is very interesting. Alpaydın et al. reported a female patient with disseminated Pseudallescheria boydii species complex infection. The patient also has CNS involvement. In fact, Pseudallescheria boydii becomes an important cause of opportunistic mycosis, especially in immunocompromised patients and for those undergoing transplantation [2] . However, the CNS infection by Pseudallescheria boydii can also be seen in immunocompetent host, especially those with the problem of near-drowning [3] .
There are many concerns in management of the patient. First, the diagnosis can be easily mistaken. Histologically, very high similarity to Aspergillus spp. can result in misdiagnosis. Second, the treatment of the patients is usually not successful. High fatality rate can be expected. Nevertheless, due to the availability of the new effective antifungal drug voriconazole, the treatment becomes more effective [4] . However, Alapydin et al. reported a case of infection due to Pseudallescheria boydii species complex (not Pseudallescheria boydii). Indeed, this complex comprises many species which might probably display distinct antifungal susceptibility profiles. Due to the increased numbers of immunocomprised hosts, the risk of getting this infection is increased and awareness of this infection, which can lead to early diagnosis and prompt treatment, by practitioner is required.
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